Literature DB >> 16138569

A case of primary aldosteronism due to unilateral adrenal hyperplasia.

Yasuyuki Katayama1, Nobuki Takata, Taiji Tamura, Akemi Yamamoto, Fumihiko Hirata, Hiroko Yasuda, Susumu Matsukuma, Yuichiro Daido, Hironobu Sasano.   

Abstract

The case of a patient with primary aldosteronism due to unilateral adrenal hyperplasia (UAH) is reported. A 43-year-old man with an 8-year history of hypertension presented at our institution with hypokalemia, increased plasma aldosterone concentration (PAC), and suppressed plasma renin activity (PRA). An abdominal CT scan showed almost normal adrenal glands with slight enlargement in the left gland. 131I-Norcholesterol adrenal scintigraphy under dexamethasone suppression showed bilaterally decreased uptake. To rule out idiopathic hyperaldosteronism, an adrenal vein sampling before and after ACTH stimulation was performed and a left-sided lateralization of PAC was observed. A left adrenalectomy was performed, and the patient had a good clinical and biochemical response. Micronodular hyperplasia was discovered in the adrenal gland histologically, and in the immunohistochemical analysis, positive staining for 3beta-hydroxysteroid dehydrogenase in micronodular lesions confirmed the diagnosis of UAH. Although UAH is a rare subset of primary aldosteronism, it is surgically correctable as a unilateral autonomous aldosterone-producing lesion. Careful investigations, including bilateral adrenal vein sampling, should be performed for the diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 16138569     DOI: 10.1291/hypres.28.379

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  7 in total

1.  Histopathological Classification of Cross-Sectional Image-Negative Hyperaldosteronism.

Authors:  Yuto Yamazaki; Yasuhiro Nakamura; Kei Omata; Kazue Ise; Yuta Tezuka; Yoshikiyo Ono; Ryo Morimoto; Yukinaga Nozawa; Celso E Gomez-Sanchez; Scott A Tomlins; William E Rainey; Sadayoshi Ito; Fumitoshi Satoh; Hironobu Sasano
Journal:  J Clin Endocrinol Metab       Date:  2017-04-01       Impact factor: 5.958

Review 2.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

3.  Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?

Authors:  Omair A Shariq; Kabir Mehta; Geoffrey B Thompson; Melanie L Lyden; David R Farley; Irina Bancos; Benzon M Dy; William F Young; Travis J McKenzie
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

4.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

5.  Hypertension associated with rhabdomyolysis may also be caused by unilateral adrenal hyperplasia.

Authors:  Panagiotis Kotsaftis; Christos Savopoulos; Dimitrios Agapakis; Reveka Kiparoglou; Apostolos I Hatzitolios
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-03       Impact factor: 3.738

Review 6.  New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

7.  Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report.

Authors:  Panagiotis Kotsaftis; Christos Savopoulos; Dimitrios Agapakis; George Ntaios; Valentini Tzioufa; Vasilios Papadopoulos; Epaminondas Fahantidis; Apostolos Hatzitolios
Journal:  Cases J       Date:  2009-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.